Abstract
The present study describes a novel pharmaceutical formulation of coenzyme Q10, viz. submicron-sized dispersions of the substance prepared by emulsification of molten coenzyme Q10 in an aqueous phase. Photon correlation spectroscopy reveals mean diameters of 60 to 300 nm depending on process parameters. Coenzyme Q10 nanoparticles remain stable on storage for more than 30 months. Lipophilic drugs can be incorporated into the nanoparticles demonstrating their potential use as a drug carrier system. Transmission electron micrographs of freeze-fractured replica show spherical particles with an amorphous core. Cryo-electron microscopy reveals the coexistence of small unilamellar vesicles in phospholipid stabilized dispersions. Thermoanalysis and X-ray studies indicate that the dispersed and emulsified coenzyme Q10 does not recrystallize even at 4°C over 30 months. These agree with 1H NMR data which demonstrate that coenzyme Q10 molecules have a high mobility when formulated as nanoparticles and that colloidally dispersed coenzyme Q10 remains in the state of a supercooled melt. Despite the high melting point of the bulk material, coenzyme Q10 dispersions represent no suspensions but O/W emulsions according to the IUPAC definition (1).
Similar content being viewed by others
REFERENCES
D. H. Everett. Report of the Commission on Colloid and Surface Chemistry of the Physical Chemistry Devision. Pure Appl. Chem. 31:577–638 (1972).
R. L. Juliano and D. Stamp. Effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochim. Biophys. Res. Comm. 63:651–658 (1975).
M. Bisrat, E. K. Anderberg, M. I. Barnett and C. Nyström. Physicochemical aspects of drug release. XV. Investigation of diffusional transport in dissolution of suspended, sparingly soluble drugs. Int. J. Pharm. 80:191–201 (1992).
A. T. Florence and D. Attwood. Physicochemical Principles of Pharmacy, Macmillan, London 1981.
G. Buckton and A. E. Beezer. The relationship between particle size and solubility. Int. J. Pharm. 82:R7–R10 (1992).
H. Kishi, N. Kanamori, S. Nishii, E. Hiraoka, T. Okamoto and T. Kishi. Metabolism of exogenous coenzyme Q10 in vivo and the bioavailability of coenzyme Q10 preparations in Japan. In: K. Folkers, Y. Yamamura (eds.), Biomedical and Clinical Aspects of Coenzyme Q, Vol. 4, Elsevier, Amsterdam, 1984, pp. 131–142.
C. Bogentoft, P. O. Edlund, B. Olsson, L. Widlund and K. Westesen. Biopharmaceutical aspects of intravenous and oral administration of coenzyme Q10. In: K. Folkers, G. P. Littaru and T. Yamagami (eds.), Biomedical and Clinical Aspects of Coenzyme Q, Vol. 6, Elsevier, Amsterdam, 1991, pp. 215–224.
B. Siekmann and K. Westesen. Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1:123–126 (1992).
T. Ramasarma. Lipid Quinones. In R. Paoletti and D. Kritchevski (eds.) Adv. Lipid Res., Vol. 6, Academic Press, New York, 1968, pp. 107–180.
K. Westesen, B. Siekmann and M. H. J. Koch. Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int. J. Pharm. 93:189–199 (1993).
F. McNeil-Watson and A. Parker. Comparison of methods for high resolution sub-micron sizing by quasi-elastic light scattering (PCS). In: R. A. Williams, N. C. de Jaeger (eds.), Advances in Measurement and Control of Colloidal Processes, Butterworth-Heinemann Ltd., Oxford 1991, pp. 421–434.
M. H. J. Koch and J. Bordas. X-ray diffraction and scattering on disordered systems using synchrotron radiation. Nucl. Instrum. Methods 208:461–469 (1983).
P. Walstra. Formation of emulsions. In P. Becher (ed.), Encyclopedia of Emulsion Technology, Vol. 1, Marcel Dekker, New York, pp. 57–127.
A. Roda, A. F. Hofmann and K. J. Mysels. The influence of bile salt structure on self-association in aqueous solutions. J. Biol. Chem. 258:6362–6370 (1983).
K. Westesen and B. Siekmann. Comparison of parenteral lipid emulsions and solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 40(Suppl.):35 S (1994).
K. Westesen and T. Wehler. Physicochemical Characterization of a Model Intravenous Emulsion. J. Pharm. Sci. 81:777–786 (1992).
K. Westesen and T. Wehler. Investigation of the Particle Size Distribution of a Model Intravenous Emulsion. J. Pharm. Sci. 82:1237–1244 (1993).
W. G. Proctor. An introduction to NMR. J. Am. Oil Chem. Soc. 48:1–3 (1971).
H. Günter. NMR-Spektroskopie, Thieme Verlag, Stuttgart, 1983.
Arzneibüro der ABDA. Pharmazeutische Stoffliste (List of Pharmaceutical Substances), 8th edn., Werbe-und Vertriebsgesellschaft Deutscher Apotheker, Frankfurt (Main), 1990.
R. M. Atkinson, C. Bedford, K. J. Child and E. G. Tomich. Effect of particle size on blood griseofulvin-levels in man. Nature 193:588–589 (1962).
B. Siekmann and K. Westesen. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surfaces B: 3:159–175 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Siekmann, B., Westesen, K. Preparation and Physicochemical Characterization of Aqueous Dispersions of Coenzyme Q10 Nanoparticles. Pharm Res 12, 201–208 (1995). https://doi.org/10.1023/A:1016270724413
Issue Date:
DOI: https://doi.org/10.1023/A:1016270724413